POWER (Pulse Width Optimized Waveform Evaluation Trial)
Phase 4 Study That Compares the DFT (Defibrillation Threshold) Efficacy of 3 Different Membrane Time Constant Based Biphasic Defibrillation Waveforms
Sponsor: Abbott Medical Devices
This PHASE4 trial investigates Sudden Cardiac Death and is currently completed. Abbott Medical Devices leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Mar 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Feb 2019 — Mar 2019 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Jun 2018 — Feb 2019 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Aug 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .